All Pathways
AnesthesiologyManagement

Postoperative Nausea and Vomiting (PONV) Management

Postoperative Nausea and Vomiting (PONV) Management: Preoperative PONV Risk Assessment → Apfel Simplified Risk Score → Risk Level? → Low Risk (0-1 facto...

Pathway Overview

12 steps

Algorithm Steps

12 total

  1. 01Start

    Preoperative PONV Risk Assessment

    Identify risk factors before surgery

  2. 02Action

    Apfel Simplified Risk Score

    Count number of risk factors present

    • 1. Female sex
    • 2. Non-smoker
    • 3. History of PONV or motion sickness
    • 4. Postoperative opioids expected
    • Risk of PONV:
    • 0 factors: 10%
    • 1 factor: 21%
    • 2 factors: 39%
    • 3 factors: 61%
    • 4 factors: 79%
  3. 03Decision

    Risk Level?

    Based on Apfel score and surgery type

  4. 04Action

    Low Risk (0-1 factors)

    No routine prophylaxis needed

    • Consider single agent for high-risk surgery
    • Have rescue antiemetics available
    • Optimize hydration
    • Avoid unnecessary opioids
  5. 05Action

    Intraoperative Risk Reduction

    Anesthetic technique modifications

    • TIVA: reduces PONV vs volatile by ~25%
    • Avoid nitrous oxide in high-risk patients
    • Regional anesthesia when appropriate
    • Multimodal analgesia (NSAIDs, acetaminophen, regional)
    • Adequate hydration (20-30 mL/kg)
    • Sugammadex > neostigmine for reversal
  6. 06Decision

    PONV in PACU?

    Patient experiencing nausea or vomiting

  7. 07Action

    Rescue Treatment

    Use DIFFERENT class than prophylaxis

    • If no prophylaxis given:
    • Ondansetron 4 mg IV
    • If ondansetron given for prophylaxis:
    • Promethazine 6.25-12.5 mg IV OR
    • Droperidol 0.625 mg IV OR
    • Dexamethasone 4-8 mg (if not given) OR
    • Propofol 20 mg IV (rescue only)
    • If multiple prophylaxis agents given:
    • Use agent from different class
    • Consider propofol 20 mg IV for rescue
  8. 08Action

    Refractory PONV

    Not responding to rescue

    • Ensure no surgical cause (ileus, bleeding)
    • Prochlorperazine 10 mg IV/IM
    • Promethazine 12.5-25 mg IV
    • Consider acupuncture (P6 point)
    • Consider NK1 antagonist if available
    • Evaluate for electrolyte imbalance
  9. 09Outcome

    PONV Managed

    Patient comfortable for discharge

  10. Path rejoins step 09Shared downstream outcome
  11. 10Action

    No PONV - Discharge Criteria Met

    Standard PACU discharge

    • Tolerating clear fluids
    • No active nausea
    • Prescribe PRN antiemetic for home if high-risk
    • Patient education on when to seek care
  12. Path rejoins step 09Shared downstream outcome
  13. 11Action

    Moderate Risk (2 factors)

    1-2 prophylactic interventions

    • CHOOSE 1-2:
    • Dexamethasone 4-8 mg IV at induction
    • Ondansetron 4 mg IV at end of surgery
    • Droperidol 0.625-1.25 mg IV
    • PLUS reduce baseline risk:
    • TIVA (propofol-based) if possible
    • Minimize opioids
    • Adequate hydration
  14. Path rejoins step 05Shared downstream outcome
  15. 12Action

    High Risk (3-4 factors)

    Multimodal prophylaxis required

    • COMBINATION THERAPY (≥2 agents from different classes):
    • Dexamethasone 4-8 mg IV at induction
    • PLUS Ondansetron 4 mg IV end of surgery
    • PLUS consider: Droperidol 0.625 mg OR
    • Scopolamine patch OR NK1 antagonist
    • REDUCE BASELINE RISK:
    • TIVA with propofol
    • Avoid nitrous oxide
    • Minimize neostigmine (use sugammadex)
    • Multimodal analgesia (minimize opioids)
    • Adequate IV fluids
  16. Path rejoins step 05Shared downstream outcome

Guideline Source

Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Individual drug availability may vary
  • Pediatric dosing differs
  • Does not address chemotherapy-induced nausea
  • Drug interactions should be checked

Applicable Regions

USEUglobal

US: Based on ASA-endorsed Fourth Consensus Guidelines

Global: Endorsed by 23 professional societies

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Postoperative Nausea and Vomiting (PONV) Management?

The Postoperative Nausea and Vomiting (PONV) Management is a management clinical algorithm for Anesthesiology. It provides a structured decision tree to guide clinical decision-making, based on Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting.

What guideline is the Postoperative Nausea and Vomiting (PONV) Management based on?

This algorithm is based on Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (DOI: 10.1213/ANE.0000000000004833).

What are the limitations of the Postoperative Nausea and Vomiting (PONV) Management?

Known limitations include: Individual drug availability may vary; Pediatric dosing differs; Does not address chemotherapy-induced nausea; Drug interactions should be checked. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Postoperative Nausea and Vomiting (PONV) Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free